skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Antiviral drug resistance in herpesviruses other than cytomegalovirus
Reviews in medical virology, 2014-05, Vol.24 (3), p.186-218
[Peer Reviewed Journal]
Copyright © 2014 John Wiley & Sons, Ltd. ;ISSN: 1052-9276 ;EISSN: 1099-1654 ;DOI: 10.1002/rmv.1787 ;PMID: 24604770
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Antiviral drug resistance in herpesviruses other than cytomegalovirus
Author:
Piret, Jocelyne
;
Boivin, Guy
Subjects:
Acyclovir - therapeutic use
;
Antiviral Agents - therapeutic use
;
Cytomegalovirus
;
Cytomegalovirus - drug effects
;
Cytomegalovirus - genetics
;
Cytomegalovirus - metabolism
;
Cytosine - analogs & derivatives
;
Cytosine - therapeutic use
;
Drug Resistance, Viral - genetics
;
Foscarnet - therapeutic use
;
Ganciclovir - therapeutic use
;
Herpes simplex virus 1
;
Herpesviridae
;
Herpesviridae Infections - drug therapy
;
Herpesviridae Infections - immunology
;
Herpesviridae Infections - virology
;
Herpesvirus 1, Human - drug effects
;
Herpesvirus 1, Human - genetics
;
Herpesvirus 1, Human - metabolism
;
Herpesvirus 2, Human - drug effects
;
Herpesvirus 2, Human - genetics
;
Herpesvirus 2, Human - metabolism
;
Herpesvirus 3, Human - drug effects
;
Herpesvirus 3, Human - genetics
;
Herpesvirus 3, Human - metabolism
;
Herpesvirus 6, Human - drug effects
;
Herpesvirus 6, Human - genetics
;
Herpesvirus 6, Human - metabolism
;
Human herpesvirus 6
;
Human immunodeficiency virus
;
Humans
;
Immunocompromised Host
;
Organophosphonates - therapeutic use
;
Varicella-zoster virus
Is Part Of:
Reviews in medical virology, 2014-05, Vol.24 (3), p.186-218
Description:
SUMMARY The discovery of acyclovir (ACV), a nucleoside analogue, more than 30 years ago, represents a milestone in the management of HSV and VZV infections. The modest activity of ACV against CMV prompted the development of another nucleoside analogue, ganciclovir, for the management of systemic and organ‐specific CMV diseases. Second‐line agents such as the pyrophosphate analogue foscarnet and the nucleotide analogue cidofovir have been approved subsequently. In contrast to ACV and ganciclovir, the latter drugs do not require selective phosphorylation by viral protein kinases to be converted into their active forms. Since the introduction of these antivirals, the emergence of drug‐resistant mutants has been constantly reported particularly in severely immunocompromised patients such as bone marrow and solid organ transplant recipients as well as HIV‐infected individuals. In this manuscript, we discuss the characteristics of the antiviral agents currently approved for the management of HSV, VZV and CMV diseases. In recent years, the resistance of CMV to antiviral drugs has been extensively reviewed. The emergence of antiviral drug resistance is also observed with other members of the Herpesviridae family, namely HSV‐1, HSV‐2, VZV and HHV‐6, which are the focus of this review. More specifically, we describe the laboratory methods for assessing drug susceptibilities, the frequency and clinical significance of drug‐resistant infections and their management. Copyright © 2014 John Wiley & Sons, Ltd.
Publisher:
England: Blackwell Publishing Ltd
Language:
English
Identifier:
ISSN: 1052-9276
EISSN: 1099-1654
DOI: 10.1002/rmv.1787
PMID: 24604770
Source:
MEDLINE
Alma/SFX Local Collection
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript